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Abstract
Protein-protein interaction networks (PINs) are rich sources of information that enable the network properties of biological
systems to be understood. A study of the topological and statistical properties of budding yeast and human PINs revealed
that they are scale-rich and configured as highly optimized tolerance (HOT) networks that are similar to the router-level
topology of the Internet. This is different from claims that such networks are scale-free and configured through simple
preferential-attachment processes. Further analysis revealed that there are extensive interconnections among middle-
degree nodes that form the backbone of the networks. Degree distributions of essential genes, synthetic lethal genes,
synthetic sick genes, and human drug-target genes indicate that there are advantageous drug targets among nodes with
middle- to low-degree nodes. Such network properties provide the rationale for combinatorial drugs that target less
prominent nodes to increase synergetic efficacy and create fewer side effects.
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Introduction
There is a growing awareness that networks of protein
interactions and gene regulations are the keys to understanding
diseases and finding accurate drug targets [1]. With the increasing
availability of genome-wide data including those on protein
interactions and gene expressions, numbers of studies have been
done on the structure and statistics of protein interactions and how
diseased genes and drug targets are distributed over the network
[2,3]. Understanding the topological and statistical properties of
interaction networks and their relationships with lethal genes as
well as currently identified drug targets should provide us with
insights into robust and fragile properties of networks and possible
drug targets for the future. We studied budding-yeast and human
protein-protein interaction networks (PINs) to identify the
architectural properties of network structures.
PINs have often been argued to be ‘‘scale-free’’ [4,5], which
mostly means they have power-law frequency-degree distributions.
However, this definition diverges from the original meaning of
being scale-free in terms of the self-similarity of geometric
properties of subject systems and there have been reports that
claim such distributions are ‘‘more normal than normal’’; thus,
they are not considered to be particularly exotic by themselves [6].
In addition, there are different network topologies with different
robustness and performance properties that maintain power-law
distributions [7]. Therefore, it is very important to identify the
architectural features of the network bearing the specific utilization
of analysis results in mind. Our goal in this study was to identify
the network topology of PINs and their relationship with lethal
genes and possible drug targets so that the statistical likelihood of
novel drug targets could be inferred.
A particularly interesting issue in the field of systems
engineering, physics, and systems biology is the trade-off between
the properties of robustness, fragility, and efficiency. Highly
optimized tolerance (HOT) theory is a conceptual framework that
can be used to explain this issue. Although a system conforming to
HOT theory is optimized for specific perturbations and has highly
efficient properties, such a system is extremely fragile against
unexpected perturbations [8,9]. Doyle et al. [8] demonstrated that
the Abline Internet2 router-level topology network conformed to
HOT theory. Nodes in the Abline network with extremely high-
degree nodes connect to a large number of low-degree nodes,
while links between these high-degree nodes are suppressed and
thus they do not form a core backbone for the whole network. A
network having similar structures to the Abline network is defined
as a HOTnet [8]. It would be very interesting to clarify whether
PINs are HOTnets or not.
The two questions addressed in this paper are: (1) what is the
global architecture of PINs? Do they follow the possible
architectural features of scale-free networks created by preferential
attachments or conform to HOT theory, and (2) are there specific
statistical features for proteins that are likely to be drug targets? To
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to analyze their structural properties using a series of analysis
methods.
Results
Scale-free Network vs. Highly Optimized Tolerance Network:
A series of analyses was carried out using budding yeast and
human PIN data to identify the topological features of PINs.
In this study, we defined low-degree nodes as nodes with
degrees of less than 5 because Han et al. [10] and Partil and
Nakamura [11] defined hubs as nodes with degrees of more than
6. We then developed a method called moving stratification by
degrees (MSD) to extract sub-networks consisting of hubs with
specific degree distributions where indices such as average cluster
coefficients would be computed (see Materials and Methods for
details). The analyses revealed that the average cluster coefficient
was very high for sub-networks consisting of hubs with degrees
from 6 to 38, while it was very low for hubs with degrees of more
than 39 in the yeast PIN (see Figure S1 and Table S1). Notably, for
hubs with degrees of less than 38, the difference in cluster
coefficients was generally significant between the yeast PIN and
random network, while there were no significant differences in
cluster coefficients for hubs with degrees of more than 39 (see
Figure S1). Therefore, we defined middle-degree nodes as those
with degrees from 6 to 38 and those with degrees of more than 39
as high. In the same manner, we defined middle- (from 6 to 30)
and high-degree (more than 31) nodes in the human PIN (see
Figure S2 and Table S2). Note that, when we used more stringent
thresholds for middle- (from 10 to 50) and high-degree (more than
51) nodes, the results did not change essentially, i.e., the average
cluster coefficient for middle-degree nodes was much higher than
that for high-degree nodes (see Tables S3 and S4).
The analyses revealed three findings: (1) the network structure
for middle-degree nodes (from 6 to 38 for yeast and from 6 to 30
for human PINs), and high-degree nodes (more than 39 for yeast
and more than 31 for human PINs) has different structures, (2)
middle-degree nodes are tightly connected and form a structure
often called a ‘‘stratus’’, and (3) high-degree nodes do not connect,
but connect with low-degree nodes, and form an ‘‘altocumulus’’
structure (Figures 1 and 2). Notably, we used more stringent
thresholds for middle- (degrees from 10 to 50) and high-degree
nodes (degrees more than 51), and found that changing the
thresholds did not essentially affect the results (see Figure S3 and
S4). These results suggests that PINs have an architecture where
highly interconnected middle-degree nodes form a core backbone
for the whole network and large numbers of low-degree nodes
connect to high-degree nodes (see Figure 2). This architecture is a
type of network that is suggested as a HOTnet, i.e., a network with
HOT properties, also seen in the Internet router-level topology
[8]. To further confirm this observation, we calculated a graph-
theoretic quantity, s(g), that defines the likelihood high-degree
nodes will be connected to one another (see Materials and
Methods for details). S(g), a value normalized against smax,
indicates that networks with tightly interconnected high-degree
nodes tend to be closer to 1.0, whereas networks with only sparsely
interconnected high-degree nodes tend to be closer to 0.0 (see
Materials and Methods for details). Doyle et al. reported randomly
generated preferential-attachment-type scale-free networks had
relatively high values such as 0.61, whereas a HOTnet exemplified
by a network abstracted from an actual Abilene Internet2 router
topology network had a value as low as 0.34 [8]. We found that the
value of S(g) for the yeast PIN was 0.25 and that of the human PIN
was 0.38. Thus, we could conclude that PINs are HOTnets.
PINs are networks with a modular structure [12–14]. Here,
modularity is defined as characteristics where there are fewer links
Figure 1. Degree dependent connectivity chart. Pn(k) gives the
probability that a link of a k-degree node is a link to a node in each sub-
network of the yeast (left) and human (right) PINs. The value of Pn(k)i s
calculated for a sub-network consisting of high-degree nodes, that
consisting of middle-degree nodes, and that consisting of low-degree
nodes. (A) Distribution of Pn(k) for the high-degree sub-network. (B)
Distribution of Pn(k) for the middle-degree sub-network. (C) Distribu-
tion of Pn(k) for the low-degree sub-network.
doi:10.1371/journal.pcbi.1000550.g001
Author Summary
Genome-wide data on interactions between proteins are
now available, and networks of protein interactions are the
keys to understanding diseases and finding accurate drug
targets. This study revealed that the architectural proper-
ties of the backbones of protein interaction networks
(PINs) were similar to those of the Internet router-level
topology by using statistical analyses of genome-wide
budding yeast and human PINs. This type of network is
known as a highly optimized tolerance (HOT) network that
is robust against failures in its components and that
ensures high levels of communication. Moreover, we also
found that a large number of the most successful drug-
target proteins are on the backbone of the human PIN. We
made a list of proteins on the backbone of the human PIN,
which may help drug companies to search more efficiently
for new drug targets.
Structure of Protein Networks
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limited links between high-degree nodes (hubs), whereas there are
links between hubs and low-degree nodes. This is a feature that
was also confirmed in this study (see Figure 2). Modularity in PINs
implies that networks have two features [13]: First, functional units
may be composed of many low-degree nodes that are directly
connected to a hub node. Second, confusion between modules is
avoided by avoiding direct connection between hubs. While there
are arguments against this claim that hubs are tightly connected
because they need to influence one another to achieve an
integrated function for the whole system [15], analysis results
indicate that such integration is most likely to take place via
middle-degree nodes instead of high-degree nodes (see Figure 2).
The distribution of essential genes, synthetic genes, and other
genes are shown in Figure 3. It is interesting to note that both
essential genes and synthetic lethal genes have similar distributions.
The average degree of essential proteins is 4.95 and that of synthetic
lethal proteins is 4.40. However, the Wilcoxon rank sum test
demonstrated that there is no statistical significance between them
(P=0.334). In either case, essential and synthetic lethal proteins are
concentrated on middle-degree nodes and high-degree nodes.
However, the average degree among syntheticsickgenes is 4.07 and
this is significantly lower than that among synthetic lethal genes
(P=0.0015). This means genes that have less severe impact are
distributed toward regions with a lower-degree distribution.
Scale-richness: The power law distribution often characterized
for scale-free networks only means that local frequency-degree
distributions are independent of location along the degree axis,
rather than self-similarity of network structures. However, Tanaka
demonstrated that bacterial metabolic networks are scale rich in
the sense there are different categories of metabolites and enzymes
depending on the degree of nodes [16]. A group of nodes with
high degree tends to be composed of currency molecules such as
ATP and a group of nodes with low degree mostly consists of
enzymes involved in specific cellular functions. In this study, we
investigated if the frequency-degree distribution of proteins for
each functional category exhibited the scale-rich characteristics
reported by Tanaka. Figures 4 and S5 correspond to frequency-
degree plots for proteins in different functional categories in the
yeast PIN and the human PIN. The functional categories were
assigned based on the GO slim ontology. As shown in the figures,
the degree distribution patterns differ among functional categories.
Moreover, proteins with different GO slim annotations have
different average degrees (See Tables S5 and S6). Note that many
functional categories have significantly higher (or lower) average
degrees than the whole PINs (See Tables S5 and S6). These results
suggest that the yeast and human PINs are scale-rich.
Drug Targets: Drug-target molecules are distributed over low-
to middle-level degree nodes with higher probability on middle-
degree nodes. Consistent with reports already published, the
average degree among drug-target nodes (4.74) is higher than the
average degree among all nodes (4.06).
The distribution of known drug targets is shown in Figure 5 and
this is predominantly distributed to middle-degree nodes and
Figure 2. Cloud topology in yeast and human PINs. Grey, red, and blue nodes correspond to low-, middle-, and high-degree nodes. Grey, red,
green, and blue links correspond to links between low- and high-degree nodes, those between middle-degree nodes, those between middle- and
high-degree nodes, and those between high-degree nodes. For clarity, low- and middle-degree nodes that have no links to high-degree nodes have
been omitted. (A) Altocumulus and stratus structures in the yeast PIN. (B) Stratus structure in the yeast PIN. (C) Altocumulus structure in the yeast
PIN. (D) Altocumulus and stratus structure in the human PIN. (E) Stratus structure in the human PIN. (F) Altocumulus structure in the human PIN.
doi:10.1371/journal.pcbi.1000550.g002
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targets for high-degree nodes. The distribution of drug targets for
cancer and non-cancerous diseases are in sharp contrast. While
the average degree of target nodes for cancer drugs was 7.82, the
targets for non-cancerous diseases scored only 4.24 (P=0.01).
Moreover, we found that the proportion of drug targets among
low-degree proteins were similar to random expectation. Figure 6
shows distribution of drug targets marked on degree-rank plot.
The drug target molecule that has highest degree is Src with 41
which is the target for drugs such as Dasatinib. Target molecules
for anti-cancer drugs are shifted toward high degree nodes
compare against average and non-anti-cancer drugs.
Discussion
A series of analyses revealed that both the budding yeast and
human PINs are scale-rich and have HOT networks. There are
extensive interconnections among middle-degree nodes that form
the backbone of the network (see Figure 2). Most drug-target genes
concentrate on middle-degree nodes and parts of low-degree
nodes, but not on high-degree nodes. Interestingly, Feldman et al.
(2008) [17] reported that genes harboring inherited disease
mutations also concentrated on middle-degree nodes. Because of
the potential lethality observed in budding yeast (Figure 3A) and
reported high lethality in mouse knockout [2], high-degree nodes
are unlikely to be preferred drug targets or genes with disease
mutations. Since oncogenes tend to be high-degree nodes, they are
less likely to be drug targets, or one has to accept major potential
side effects. The fact that the degree distribution of cancer-drug
targets is higher than that of non-cancer-drug targets is consistent
with the report by Yao and Rzhetsky [18]. Since high-degree
nodes are predominantly connected with low-degree nodes
(Figures 1, 2, S3, and S4), the elimination of high-degree nodes
is likely to affect large numbers of low-degree nodes. This may
result in unacceptable side effects since a group of genes that bear
certain functions may be made collectively dysfunctional. Detailed
case studies are warranted to test and verify this possible
interpretation. However, the average degree distribution of
synthetic sick genes (4.07) is less than that of essential genes
(4.95) and synthetic lethal genes (4.40). This implies that a drug
design strategy to generate synergetic effects by targeting less
important targets can be a reasonable option because each
compound in such drugs can select targets that have less impact on
the overall system alone.
We found that middle-level degree nodes are the optimal targets
for therapeutic drugs. A similar observation was reported by Yao
and Rzhetsky [18], although they measured the mean degree
among drug targets. In this study, we investigated the degree
distribution of drug targets in greater detail, because we measured
a fraction of drug targets to all nodes with degree k as well as
mapping drug targets on the network structure. It was clearly
identified most of drug targets for drugs that are currently on the
market are concentrated on middle degree nodes that are back
bone of the network and low-degree nodes that tends to have
specific function specific effects. One of novel findings here is that
the distribution of drug targets for low-degree nodes is similar to
random expectation, indicating that there are a certain number of
low-degree drug targets. From these results, we can expect that the
most advantageous targets for combinatorial drugs could be
among low-degree nodes because these could have less severe
impact on the overall system of the human body. This is consistent
with the idea of ‘‘long-tail drugs’’[19].
Are there any relationships between structures in molecular
networks (i.e., scale-richness in PINs) and the properties of their
underlying genome? Rzhetsky and Gomez [20] proposed a
stochastic model describing the evolutionary growth of molecular
networks. Their model predicts that, in a molecular network, the
shape of the degree distribution will be similar to the shape of the
distribution of domains in the genome. Actually, they showed that,
in the case of the entire yeast PIN, both the degree distribution
and the distribution of the domain followed a power law.
Therefore, it might be interesting to see whether, for each
functional category, the shape of the degree distribution was
similar to that of the domain distribution, when the entire
architecture of domains in genomes becomes available.
In this study, we assumed that the PINs represented all functions
of genes. However, the PINs are just composed of binary protein-
protein binding and proteins have other types of functions, such as
catalyzing reactions with non-protein substrates. Therefore, PINs
reflect a subset of the entire cellular function. This indicates that, if
the complete picture for cellular protein functions could be
considered, our conclusions from the PINs may diverge from what
we presented here. Moreover, at present, the yeast and human
PINs represent incomplete pictures of the actual entire PINs of
these organisms. When data on all the actual entire PINs become
available, we intend to examine all the actual entire PINs to see
whether similar observations to those in this study can be made or
not.
It is interesting to note that both PINs and the Internet topology
are HOTnets. Many of the observed properties in Internet router
topology may be applied to PINs as well. Such properties include
Figure 3. Degree distribution of essential proteins, synthetic
lethal proteins, synthetic sick proteins, and proteins that do
not belong to any of these (normal proteins). (A) Fraction of
essential proteins to all proteins with degree k (red triangles). (B)
Fraction of synthetic lethal proteins to all proteins with degree k (red
triangles). (C) Fraction of synthetic sick proteins to all proteins with
degree k (red triangles). (D) Fraction of normal proteins to all proteins
with degree k (red triangles). Dashed lines in black give the probability
that a randomly selected protein is essential, synthetic lethal, synthetic
sick, or normal. Dashed lines in red represent fraction of essential,
synthetic lethal, synthetic sick, or normal proteins to all proteins with
degree from k25t ok+5, when k#38. When k.38, dashed lines in red
represent fraction of essential, synthetic lethal, synthetic sick, or normal
proteins to all proteins with degrees more than 38.
doi:10.1371/journal.pcbi.1000550.g003
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PLoS Computational Biology | www.ploscompbiol.org 4 October 2009 | Volume 5 | Issue 10 | e1000550Figure 4. Scale-richness in yeast PIN. Each diagram shows cumulative degree distributions of proteins in each functional group. The name above
each diagram denotes the name of the functional category with which the cumulative degree distribution was examined.
doi:10.1371/journal.pcbi.1000550.g004
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has been reported that analysis using several possible router
topologies found that a HOTnet configuration was most efficient,
providing more maximum overall bandwidth to users than that
with other network-configuration approaches such as random and
preferential attachment [21]. The implication is that biological
Figure 5. Distribution of drug targets. (A) Degree distribution. Red triangles represent fraction of drug-target proteins to all proteins with
degree k. The dashed line in black gives the probability that a randomly selected protein is a drug target. (B) Distribution on network topology. Drugs
targets (yellow circles) are mapped on human PIN network topology shown in Figure 2D.
doi:10.1371/journal.pcbi.1000550.g005
Figure 6. The long tails in degree distribution of drug targets, targets for cancer, and those for non-cancerous diseases. Proteins
were ranked in decreasing order of their degree k. (A) Rank of a protein with degree k. (B) Rank of a drug target with degree k. (C) Rank of a target
for cancer diseases with degree k. (D) Rank of a target for non-cancerous diseases with degree k. Red, green, and blue lines represent fraction of drug
targets, targets for cancer diseases, and those for non-cancerous diseases to all proteins with rank from rank20.1N to rank+0.1N (N represents
number of proteins in the human PIN). (E) Red, green, and blue lines represent fraction of drug targets, targets for cancer disease, and those for non-
cancerous disease with rank from rank20.1N to rank+0.1N to all drug targets, all targets for cancer diseases, and those for non-cancerous diseases,
respectively.
doi:10.1371/journal.pcbi.1000550.g006
Structure of Protein Networks
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series of analyses presented in this report indicate that there are
changes whereby we can rationally design drugs by taking into
account network properties, and additional insights from engi-
neering and physics may further extend our opportunities for
exploring network-based biology.
Materials and Methods
PINs, GO data, and essential genes. Yeast PIN data were
obtained from the Munich Information Center for Protein
Sequences (MIPS) database (http://mips.gsf.de) [22] and human
PIN data were obtained from Rual et al. [23]. The yeast (or
human) PIN contained 4,153 (or 3,023) proteins and 7,417 (or
6,149) non-redundant interactions. The GO slim dataset for the
yeast PIN was from the ftp site of the Saccharomyces Genome
Database (SGD) (ftp://genome-ftp.stanford.edu/pub/yeast/
literature_curation/) [22] and that for the human PIN was from
the European Bioinformatics Institute (EBI) (ftp://ftp.ebi.ac.uk/
pub/databases/GO/goa/HUMAN/). The list of essential genes
from SGD [22] contained 889 essential genes that were mapped to
the yeast PIN.
Synthetic lethal and synthetic sick proteins. We obtained
a list of synthetic lethal and sick interactions from Tong et al. [24].
There were 735 proteins having at least one synthetic lethal
interaction and we defined these proteins as synthetic lethal
proteins. However, there were 816 proteins having at least one
synthetic sick interaction, of which 310 proteins had no synthetic
lethal interactions. We defined these 310 proteins as synthetic sick
proteins. 538 synthetic lethal proteins and 209 synthetic sick
proteins were mapped to the yeast PIN.
Drug-target proteins. To analyze the statistical features of
drug-target genes, we obtained a list of proteins that were targets
of FDA-approved and experimental drugs from Yildirim et al. [3].
This list contained 1,013 drug-target proteins, of which 236 were
mapped to the human PIN. To generate a list of drug-disease
associations, we mapped drugs to diseases by investigating
information on drugs obtained from the DrugBank database
[25] (information on drugs is contained in the ‘‘indications’’ field
in the DrugBank database). Then, by using the list of drug-disease
associations, we divided drug-target proteins into two groups:
target proteins for cancer drugs and those for non-cancerous
diseases. The human PIN contained 33 target proteins for cancer
and 203 for non-cancerous diseases.
Random network. We generated a random network by
using the method proposed by Maslov and Sneppen [13], where
the following procedures were performed. First, two links in a
network were chosen randomly. Assume that one link connects
nodes A and B, and the other connects nodes C and D. Second,
these links were rewired by exchanging their connecting partners.
That is, nodes A and D were connected, and nodes B and C were
connected. We repeated these two procedures 1,000E times (E is
the number of interactions in the original network) to generate a
random network. Note that the method did not alter the degree
distribution.
Cluster coefficient. The cluster coefficient of node i is
defined as Ci=2ei/ki(ki21), where ki is the degree of node i and ei is
the number of links connecting ki neighbors of node i to one
another [26]. When ki is zero or one, Ci is defined as zero. Ci is
equal to one when all neighbors of node i are fully connected to
one another, while Ci is zero when none of the neighbors are
connected to one another.
Moving stratification by degree. A method of analysis
termed moving stratification by degree (MSD) was developed and
used to compare three networks, the budding yeast PIN, the
human PIN, and a randomly generated network with exactly the
same degree distribution as the PINs. Hubs were defined as nodes
with degrees of more than six [10,11]. MSD was used to extract
sub-networks consisting of hubs with degrees from kc2m to kc+m.
In this study, we used m=1, 3, 5, and 7. Since a hub is defined as a
node with degrees of more than 6, we used initial values of kc=7,
9, 11, and 13. Then, kc was scanned up to 300 with step size 1. For
each initial value (kc=7, 9, 11, and 13), MSD extracted 293, 291,
289, and 287 sub-networks, respectively. For these sub-networks,
only hub nodes were included. In the following analysis, data from
m=5 were used because changing m did not significantly alter the
results.
The average cluster coefficient ,C(kc)., average shortest path
length ,L(kc)., betweeness centrality Bt(kc), and node ratio
included in largest components Gc(kc) in each sub-network from
the PINs were compared with each value from random networks.
The sub-networks were tightly connected when the average cluster
coefficient was high. While there were no significant differences in
the average cluster coefficient between the PINs and random
networks for high kc (kc.38 for the yeast PIN and kc.30 for the
human PIN) (Figures S1A and S2A), the average cluster coefficient
for PINs was significantly higher than that for the random
networks. There were no significant differences in ,L(kc). and
Gc(kc) between the PINs and random networks (Figures S1B, S1C,
S2B, and S2C). It is interesting to note that there were no
significant differences in global properties (i.e., betweeness
centrality Bt(kc)) between PINs and random networks (see Figures
S1D and S2D), although difference in local properties (i.e.,
average cluster coefficient ,C(kc).) were significant between PINs
and random networks (see Figures S1A and S2A).
The fraction of essential proteins to all proteins in each sub-
network (FLC(kc)) was investigated for the budding yeast PIN
(Figure S1E). The fraction of drug targets to all proteins in each
sub-network (FDT(kc)) was investigated for the human PIN (Figure
S2E).
There were no known drug-target proteins when kc was over 50
(FDT(kc)=0 for kc.50. See Table S4). This means that high-degree
proteins were unlikely to be drug targets. However, FDT(kc)i s
significantly higher than random expectation when kc is between
11 and 32. Thus, middle-degree proteins are biologically
important and can be drug-target proteins. Table S7 lists
middle-degree proteins and their functions categorized by GO
annotation. We can expect novel drug targets to be included in the
list.
Further analyses were carried out by partitioning a network into
three sub-networks, a sub-network consisting of low-degree nodes
(degrees from 1 to 5), that consisting of middle-level degree nodes
(degrees from 6 to 38 for the yeast PIN and from 6 to 30 for the
human PIN), and that consisting of high-degree nodes (degrees
more than 39 for the yeast PIN and more than 31 for the human
PIN). Middle-level nodes formed a tightly coupled stratus structure
whereas high-degree nodes formed a modularized altocumulus
structure.
Tables S1 and S2 show that middle-degree nodes formed a
high-density tightly coupled structure and a middle-degree sub-
network had higher average cluster coefficients than other sub-
networks. The average cluster coefficient of PINs without nodes in
the middle-degree sub-network was substantially lower than that of
the original PIN. In addition, the average shortest distance in the
middle-degree sub-network was almost equal to that of the entire
PINs. Most nodes in the entire PINs or middle-degree sub-network
(over 95% of nodes) were included in the largest component.
However, this is not a case for low-degree or high-degree sub-
Structure of Protein Networks
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strongly influence the statistical characteristics of the whole PIN.
The whole network architecture seems to have tightly connected
middle-degree nodes that are connected to high-degree nodes, and
a large number of low-degree nodes are mostly connected to high-
degree nodes (see Figure 2). Moreover, we used more stringent
thresholds for middle- and high-degree nodes and found that
changing the thresholds did not essentially affect the results (i.e.,
the average cluster coefficient, average shortest path length, or GC)
(see Tables S3 and S4).
The series of analyses thus far indicates that the functional role
for proteins included in low-degree, middle-degree, and high-
degree sub-networks are totally different. This means that the yeast
and human PINs are not scale-free in terms of the composition of
the functional role of proteins. Proteins with each functional group
have a characteristic degree distribution. To investigate the degree
distribution of proteins in each functional category, we annotated
proteins in the yeast and human PINs by using the GO slim
biological process ontology. As shown in Figures 4 and S5, there
are different degree-distribution patterns for proteins from
different functional categories. This suggests that a scale-free
distribution emerges from the composition of different functional
protein groups each of which has scale-dependent degree
distributions. Thus, from the functional distribution, the yeast
and human PINs are scale-rich.
S(g) value. Before giving a definition for the S(g) value, let us
first define some notations. Let n be the number of nodes in a
network and ki be the degree of node i. D={k1,k2,…,kn} represents
a given degree distribution and G(D) denotes the set of all
connected networks having the same degree distribution, D. For a
network, g, having degree distribution D, graph-theoretic quantity
s(g) is defined as s(g)=S(i,j)ME(g)kikj, where E(g) is the set of links in the
network. smax is defined as smax=max{s(g): gMG(D)} and we
calculated the value of smax by using the algorithm devised by
Alderson et al. [7]. S(g), the value normalized against smax,i s
defined as S(g)=s(g)/smax [8]. In this paper, we calculated the value
of S(g) in the yeast and human PINs.
Supporting Information
Figure S1 Statistics of sub-networks generated by MSD (yeast
PIN). Red triangles and black squares show the values for the yeast
PIN and random network, respectively. The results for random
network were obtained by taking the average among 100 random
networks. (A) Distribution of ,C(kC).. (B) Distribution of
,L(kC).. (C) Distribution of GC(kC). (D) Distribution of
PLC(kC). The dashed line represents the probability that a
randomly selected protein is a lethal protein.
Found at: doi:10.1371/journal.pcbi.1000550.s001 (1.37 MB TIF)
Figure S2 Statistics of sub-networks generated by MSD (human
PIN). Red triangles and black squares show the values for the
human PIN and random network, respectively. The results for
random network were obtained by taking the average among 100
random networks. (A) Distribution of ,C(kC).. (B) Distribution
of ,L(kC).. (C) Distribution of GC(kC). (D) Distribution of
PDT(kC). The dashed line in black represents the probability that
a randomly selected protein is a drug target.
Found at: doi:10.1371/journal.pcbi.1000550.s002 (1.35 MB TIF)
Figure S3 Degree Dependent Connectivity Chart with stringent
thresholds. Pn(k) gives the probability that a link of a k-degree
node is a link to a node in each sub-network of the yeast (left) and
human (right) PINs. The value of Pn(k) is calculated for a sub-
network consisting of high-degree nodes, that consisting of middle-
degree nodes, and that consisting of low-degree nodes. (A)
Distribution of Pn(k) for the high-degree sub-network. (B)
Distribution of Pn(k) for the middle-degree sub-network. (C)
Distribution of Pn(k) for the low-degree sub-network.
Found at: doi:10.1371/journal.pcbi.1000550.s003 (0.26 MB TIF)
Figure S4 Cloud topologies in yeast and human PINs with
stringent thresholds. Grey, red, and blue nodes correspond to low-,
middle-, and high-degree nodes. Grey, red, green, and blue links
correspond to links between low- and high-degree nodes, those
between middle-degree nodes, those between middle- and high-
degree nodes, and those between high-degree nodes. For clarity,
low- and middle-degree nodes that have no links to high-degree
nodes have been omitted. (A) Altocumulus and stratus structures in
the yeast PIN. (B) Stratus structure in the yeast PIN. (C)
Altocumulus structure in the yeast PIN. (D) Altocumulus and
stratus structure in the human PIN. (E) Stratus structure in the
human PIN. (F) Altocumulus structure in the human PIN.
Found at: doi:10.1371/journal.pcbi.1000550.s004 (2.83 MB TIF)
Figure S5 Scale-richness in human PIN. Each diagram shows
cumulative degree distributions of proteins in each functional
group. The name above each diagram denotes the name of the
functional category with which the cumulative degree distribution
was examined.
Found at: doi:10.1371/journal.pcbi.1000550.s005 (0.45 MB TIF)
Table S1 Statistics of sub-networks in the yeast PIN. a. number
of nodes b. average shortest path legth c. fraction of nodes
contained in a largest component to all nodes contained in a sub-
network d. average cluster coefficient e. betweeness centrality f.
fraction of essential nodes to all nodes contained in a sub-network
g. a sub-network consist of low-degree nodes h. a sub-network
consist of middle-degree nodes i. a sub-network consist of high-
degree nodes j. a sub-network consist of low- and middle-degree
nodes k. a sub-network consist of low- and high-degree nodes.
Found at: doi:10.1371/journal.pcbi.1000550.s006 (0.04 MB
DOC)
Table S2 Statistics of sub-networks in the human PIN. a. See
Table S1. b. fraction of drug-target nodes contained in a sub-
network to all nodes contained in the sub-network.
Found at: doi:10.1371/journal.pcbi.1000550.s007 (0.04 MB
DOC)
Table S3 Statistics of sub-networks in yeast PIN with stringent
thresholds for middle- and high-degree nodes. a. See Table S1.
Found at: doi:10.1371/journal.pcbi.1000550.s008 (0.04 MB
DOC)
Table S4 Statistics of sub-networks in human PIN with stringent
thresholds for middle- and high-degree nodes. a. See Table S2.
Found at: doi:10.1371/journal.pcbi.1000550.s009 (0.04 MB
DOC)
Table S5 Degrees of the genes in yeast PIN belonging to each
functional category. a. Mean degree among the proteins contained
in each functional category. b. Number of proteins in each
functional category. c. ***, **, and * represents that a given value is
significantly higher (or lower) than average degree among proteins
belonging other functional categories with P,0.001, P,0.01, and
P,0.05, respectively, by the Wilcoxon rank-sum two-sample test
with the Bonferronni correction.
Found at: doi:10.1371/journal.pcbi.1000550.s010 (0.06 MB
DOC)
Table S6 Degrees of the genes in human PIN belonging to each
functional category. a. See Table S5.
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DOC)
Table S7 Middle degree proteins in human PIN and their
functions.
Found at: doi:10.1371/journal.pcbi.1000550.s012 (2.79 MB
DOC)
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